187 related articles for article (PubMed ID: 20567884)
1. NADPH oxidase inhibition ameliorates cardiac dysfunction in rabbits with heart failure.
Liu Y; Huang H; Xia W; Tang Y; Li H; Huang C
Mol Cell Biochem; 2010 Oct; 343(1-2):143-53. PubMed ID: 20567884
[TBL] [Abstract][Full Text] [Related]
2. [Effects of NADPH oxidase inhibition on cardiac function and myocardial calcium regulatory proteins in rabbits with heart failure].
Liu Y; Huang H; Tang YH; Li HT; Wang X; Huang CX
Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Oct; 37(10):883-6. PubMed ID: 20137536
[TBL] [Abstract][Full Text] [Related]
3. Tanshinone IIA attenuates heart failure via inhibiting oxidative stress in myocardial infarction rats.
Chen R; Chen W; Huang X; Rui Q
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33786621
[TBL] [Abstract][Full Text] [Related]
4. The NADPH oxidase inhibitor apocynin improves cardiac sympathetic nerve terminal innervation and function in heart failure.
Wang K; Zhu ZF; Chi RF; Li Q; Yang ZJ; Jie X; Hu XL; Han XB; Wang JP; Li B; Qin FZ; Fan B
Exp Physiol; 2019 Nov; 104(11):1638-1649. PubMed ID: 31475749
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction.
Qin F; Simeone M; Patel R
Free Radic Biol Med; 2007 Jul; 43(2):271-81. PubMed ID: 17603936
[TBL] [Abstract][Full Text] [Related]
6. TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves.
Hagler MA; Hadley TM; Zhang H; Mehra K; Roos CM; Schaff HV; Suri RM; Miller JD
Cardiovasc Res; 2013 Jul; 99(1):175-84. PubMed ID: 23554457
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen-containing saline alleviates pressure overload-induced interstitial fibrosis and cardiac dysfunction in rats.
Yang J; Wu S; Zhu L; Cai J; Fu L
Mol Med Rep; 2017 Aug; 16(2):1771-1778. PubMed ID: 28656216
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol protects against lipopolysaccharide-induced cardiac dysfunction by enhancing SERCA2a activity through promoting the phospholamban oligomerization.
Bai T; Hu X; Zheng Y; Wang S; Kong J; Cai L
Am J Physiol Heart Circ Physiol; 2016 Oct; 311(4):H1051-H1062. PubMed ID: 27591219
[TBL] [Abstract][Full Text] [Related]
9. Activation of NADPH oxidase mediates increased endoplasmic reticulum stress and left ventricular remodeling after myocardial infarction in rabbits.
Li B; Tian J; Sun Y; Xu TR; Chi RF; Zhang XL; Hu XL; Zhang YA; Qin FZ; Zhang WF
Biochim Biophys Acta; 2015 May; 1852(5):805-15. PubMed ID: 25615792
[TBL] [Abstract][Full Text] [Related]
10. NADPH oxidase mediates the expression of MMP-9 in cerebral tissue after ischemia-reperfusion damage.
Tang X; Zhong W; Tu Q; Ding B
Neurol Res; 2014 Feb; 36(2):118-25. PubMed ID: 24131725
[TBL] [Abstract][Full Text] [Related]
11. Myocardial MMP-2 contributes to SERCA2a proteolysis during cardiac ischaemia-reperfusion injury.
Roczkowsky A; Chan BYH; Lee TYT; Mahmud Z; Hartley B; Julien O; Armanious G; Young HS; Schulz R
Cardiovasc Res; 2020 Apr; 116(5):1021-1031. PubMed ID: 31373602
[TBL] [Abstract][Full Text] [Related]
12. Trimetazidine inhibits pressure overload-induced cardiac fibrosis through NADPH oxidase-ROS-CTGF pathway.
Liu X; Gai Y; Liu F; Gao W; Zhang Y; Xu M; Li Z
Cardiovasc Res; 2010 Oct; 88(1):150-8. PubMed ID: 20534773
[TBL] [Abstract][Full Text] [Related]
13. Nox2 NADPH oxidase promotes pathologic cardiac remodeling associated with Doxorubicin chemotherapy.
Zhao Y; McLaughlin D; Robinson E; Harvey AP; Hookham MB; Shah AM; McDermott BJ; Grieve DJ
Cancer Res; 2010 Nov; 70(22):9287-97. PubMed ID: 20884632
[TBL] [Abstract][Full Text] [Related]
14. The correlation between angiogenesis and abnormal expression of SERCA2a, phospholamban and the endothelin pathway in heart failure, and improvement by puerarin.
He H; Shi M; Yang J; Zeng X; Qiao H; Wu L; Li L
Phytother Res; 2008 Jul; 22(7):948-56. PubMed ID: 18389490
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase-9 deletion attenuates myocardial fibrosis and diastolic dysfunction in ageing mice.
Chiao YA; Ramirez TA; Zamilpa R; Okoronkwo SM; Dai Q; Zhang J; Jin YF; Lindsey ML
Cardiovasc Res; 2012 Dec; 96(3):444-55. PubMed ID: 22918978
[TBL] [Abstract][Full Text] [Related]
16. Activin type II receptor ligand signaling inhibition after experimental ischemic heart failure attenuates cardiac remodeling and prevents fibrosis.
Castillero E; Akashi H; Najjar M; Ji R; Brandstetter LM; Wang C; Liao X; Zhang X; Sperry A; Gailes M; Guaman K; Recht A; Schlosberg I; Sweeney HL; Ali ZA; Homma S; Colombo PC; Ferrari G; Schulze PC; George I
Am J Physiol Heart Circ Physiol; 2020 Feb; 318(2):H378-H390. PubMed ID: 31886717
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of cardiac function and expression and activity of myocardial calcium regulatory proteins in rabbit systolic and diastolic heart failure models.].
Wang L; Zhang SJ; Wang HP; Zou C; Liu ZH
Sheng Li Xue Bao; 2009 Dec; 61(6):551-8. PubMed ID: 20029689
[TBL] [Abstract][Full Text] [Related]
18. NADPH oxidase inhibitor apocynin prevents atrial remodeling in alloxan-induced diabetic rabbits.
Qiu J; Zhao J; Li J; Liang X; Yang Y; Zhang Z; Zhang X; Fu H; Korantzopoulos P; Liu T; Li G
Int J Cardiol; 2016 Oct; 221():812-9. PubMed ID: 27434350
[TBL] [Abstract][Full Text] [Related]
19. Reversal of systemic hypertension-associated cardiac remodeling in chronic pressure overload myocardium by ciglitazone.
Henderson BC; Sen U; Reynolds C; Moshal KS; Ovechkin A; Tyagi N; Kartha GK; Rodriguez WE; Tyagi SC
Int J Biol Sci; 2007 Sep; 3(6):385-92. PubMed ID: 17848984
[TBL] [Abstract][Full Text] [Related]
20. Effect of the peptides Relaxin, Neuregulin, Ghrelin and Glucagon-like peptide-1, on cardiomyocyte factors involved in the molecular mechanisms leading to diastolic dysfunction and/or heart failure with preserved ejection fraction.
Warbrick I; Rabkin SW
Peptides; 2019 Jan; 111():33-41. PubMed ID: 29807087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
